Title: Study on Post Menopausal Ladies with Ovarian Mass – Management & Outcome
Authors: Dr Simikurian, Dr Sumangali.P.K
DOI: https://dx.doi.org/10.18535/jmscr/v5i11.106
Abstract
Background: Ovarian cancer is a common malignancy affecting Indian women and is an important cause of morbidity & mortality especially in elderly women. Main aim was to study the type of ovarian tumour in post menopausal ladies – Benign/Malignant – Histolopathological type & management and follow-up
Method: Retrospective analysis of cases from Jan 2015 – Dec 2016 (2 years)
Results: Out of 3372 admission in the gynaecology ward, incidence of ovarian masses in post menopausal ladies is 2%. Among the ovarian masses 54% were benign tumours, 4% were borderline malignancy and 42% were malignant tumours. Among malignancy serous cystadenocarcinoma accounts for 60% & mucinous cystadenocarcinoma accounts for 40%. Out of the malignant cases all are primary ovarian tumour.
Conclusion: In post menopausal age group, malignant ovarian tumours are common. Among that serous cystadenocarcinoma is more.
Keywords: ovarian cancer, postmenopausal, female genital tract.
References
- Murthy N S, Shalini S, Suman G et al. Changing trends in incidence of ovarian cancer – the Indian scenario. Asia Pac J Cancer Prev. 2009; 10: 1025 – 30
- Uma Devi K. Current status of Gynaecological cancer care in India. J Gynaecol Oncol. 2009; 20(2): 77-80
- Vergote I, Trope CG, Amant F et al. Neo adjuvant chemotherapy or primary surgery in stage IIIc or IV ovarian cancer. N Engl J Med. 2010; 363: 943 – 53
- Yeole BB, Kumar A V, Kurkure A et al. Population based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev. 2004; 5(3): 308 – 15
- Sharada SO, Sridevi TA et al. Ovarian masses – changing clinico histopathological trends – The Journal of Obstetrics & Gynaecology of India (January – February 2015); 65(1): 34 – 38
- Szender JB, Lele SB. Fallopian tube ligation or salpingectomy as means for reducing risk of ovarian cancer. AMA J Ethics. 2015; 17(9): 843 – 8
- Sopik V, Ighal J, Rosen B et al. Why have ovarian cancer mortality rates declined? Part I. Incidence Gynaecol Omcol. 2015; doi: 10.1016/ J Ygyno. 2015; 06 – 017
- Santhosh Kuriakose. Update in the management of advanced epithelial ovarian cancer. Yuva fogsi South zone conference. 2015; souvenir 72 Page no:
- Santhosh Kuriakose. Update in the management of advanced epithelial ovarian cancer. Yuva fogsi South zone conference. 2015; souvenir 72 Page no:
- Pannu HK, Bristow RE, Cohade C et al PET – Ctin recurrent ovarian cancer; initial observations. Radiographics. 2004; 24(1): 209 – 23
- Zimny M, Siggelkow W, Schroder W et al. 2 – [fluorine – 18] – fluoro – 2 deoxy – D – glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynaecol Oncol. 2001; 83(2): 310 – 5
- Nanni C, Rubello D, Farsad M et al 18F – FDG PET CT in the evaluation of recurrent ovarian cancer : a prospective study on forty one patients. Eur J Surg Oncol. 2005; 31: 792 – 7
- Sharada SO, Sridevi TA et al. Ovarian masses – changing clinico histopathol-ogical trends – The Journal of Obstetrics & Gynaecology of India (January – February 2015); 65(1): 34 – 38